Mrukmed. Lekarz Beata Madej-Mruk i Partner. Sp.p

Rzeszów 35-021

0 studies enrolling now · 1 studies all time

What they study most

Relapsed Small Cell Lung Cancer

Studies at this site

• Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed